Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 255Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Cohance Lifesciences

02 1Emay Pharmaceuticals

03 1Octavius Pharma Pvt. Ltd

04 1Lee Pharma

05 2Apotex Inc

06 2Ascent Innovative Medicines

07 1Aspire Lifesciences Pvt Ltd

08 2Endo International

09 2Kolmar Korea Co., Ltd.

10 2Laboratorio Eczane Pharma

11 1Loxim Industries

12 4Murli Krishna Pharma

13 2Orchid Pharma

14 4Pelcoat Formulations

15 2Smilax Laboratories Limited

16 2TWi Pharmaceuticals

17 11Takeda Pharmaceutical

18 2Viatris

19 4World Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEmay Pharmaceuticals is a GMP-certified API manufacturing company.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets

Dosage Strength : 20%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Emay Pharmaceuticals

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOctavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets/Micro pellets for capsules

Dosage Strength : 17; 20; 22.5; 23%; %; %; %

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Octavius Pharma

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name : Dexlansoprazole

Dosage Form : Pellets

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Capsule

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Dexlansoprazole

Brand Name :

Dosage Form : Delayed Release Pellet

Dosage Strength : 22.5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

07

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : Pellets

Dosage Strength : 17%W/W

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2017-04-19

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

09

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-06-16

Application Number : 202294

Regulatory Info : RX

Registration Country : USA

blank

10

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

11

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : DR CAPSULE

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

12

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

13

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2009-01-30

Application Number : 22287

Regulatory Info : RX

Registration Country : USA

blank

14

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXILANT SOLUTAB

Dosage Form : TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2016-01-26

Application Number : 208056

Regulatory Info : DISCN

Registration Country : USA

blank

15

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

16

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2022-09-16

Application Number : 202666

Regulatory Info : RX

Registration Country : USA

blank

17

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

18

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

DEXLANSOPRAZOLE

Brand Name : DEXLANSOPRAZOLE

Dosage Form : CAPSULE, DELAYED RELEASE;ORAL

Dosage Strength : 60MG

Packaging :

Approval Date : 2024-01-19

Application Number : 205205

Regulatory Info : RX

Registration Country : USA

blank

19

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 30MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank

20

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Dexlansoprazole

Brand Name :

Dosage Form : CAPSULE

Dosage Strength : 60MG

Packaging : 14 Or 28 Capsules

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank